Francis P. Crawley
Francis P. Crawley is the Executive Director of the Good Clinical Practice Alliance – Europe (GCPA) and the Strategic Initiative for Developing Capacity in Ethical Review (SIDCER) located in Leuven, Belgium. Francis has expertise in EU, US, international and country-specific ethics, GCP, law, and patient and community interests in health-related research. He brings 30 years of experience working closely with patients, communities, researchers, and policy-makers across disciplines. domains, and geographic regions in establishing consortia, developing patient registries, contributing to the development of biobanks, drafting data management and data protection plans, and contributing to building data repositories. He is the Chairman of the Research Data Alliance’s (RDA) Artificial Intelligence and Data Visitation Working Group (RDA AIDV-WG) and Ethics Ambassador for the EU-funded H2020 project European Open Science Cloud (EOSC) Future . He is a member of the Pistoia Alliance, Regulatory and Ethics Work Stream of the Global Alliance for Genomics & Health (GA4GH-REWS), the Virus Outbreak Data Network (VODAN) GO-FAIR, and the Research Data Publishing Ethics Working Group with FORCE11 & The Committee on Publication Ethics (COPE). He is also a member of the Ethics Working Group of the International Federation of Associations of Pharmaceutical Physicians (IFAPP). Francis has a strong background in the methodologies for designing and reviewing health-related research supported by strong communication and leadership skills as well as diplomacy with the ability to influence changes in bioethics and law. Additional strong background in the development of research, guidance, and ethics related to global diseases affecting resource-poor settings and orphan diseases in the context of leading and/or contributing to challenging projects. Wide experience (UNAIDS, WHO, and others, including local organizations and industry) in developing health-related research projects, collaborative engagements, regulatory and policy outreach, and education and training in Europe, Africa, Asia, the Americas, and Eastern Europe & Central Asia. He has had leading roles in the development of international and national guidelines, capacity-building, empowerment, and education programs for health research, including GCP, ethics review systems, and data privacy & management (a GDPR DPO), with expertise in the ethics of ML & AI. Since January 2020 he has been active in the research, ethics, data sharing, and policy discussions on COVID-19, having organized more than 40 global webinars and coordinating research across HICs and LMICs
close